8 Results for "

human M5 receptors

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "human M5 receptors" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-122203
CAS No.: 361979-40-0
Purity:  98.88%
Research Areas:  

Neurological Disease

PCS1055 dihydrochloride is a potent, selective and competitive muscarinic M4 receptor antagonist with an IC50 of 18.1 nM and a Kd of 5.72 nM. PCS1055 dihydrochloride inhibits radioligand [ 3H]-NMS binding to the M4 receptor with a Ki of 6.5 nM. PCS1055 dihydrochloride exhibits >100-fold selectivity over M1-, M3-, and M5-receptors and 30-fold selectivity at the M2 receptor. PCS1055 dihydrochloride is also a potent AChE inhibitor with IC50 s of 22 nM and 120 nM for electric eel and human AChE, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107651
CAS No.: 1208222-39-2
Purity:  99.34%
Target:  

mAChR

Research Areas:  

Metabolic Disease

VU 0365114 is a selective mAChR M5 positive allosteric modulator, with an EC50 of 2.7 μM, and >30 μM for M1, M2, M3 and M4 receptors. VU 0365114 increases insulin secretion stimulated by ACh in human β-cells .
loading...
    loading...
Cat. No.: HY-118363
CAS No.: 1186229-95-7
Target:  

mAChR

Research Areas:  

Neurological Disease

Lu AE51090 is selective muscarinic M1 receptor agonist with blood-brain barrier penetration. Lu AE51090 activates human M1 receptor with EC50 of 61 nM, while showing no significant agonism at M2-M5 receptors. Lu AE51090 exerts procognitive effects in mice. Lu AE51090 can be used for the study of Alzheimer’s disease (AD) and cognitive impairment associated with schizophrenia (CIAS) .
loading...
    loading...
Cat. No.: HY-14825A
CAS No.: 1159101-48-0
Purity:  99.86%
Synonyms: SVT-40776 D-tartrate
Target:  

mAChR

Research Areas:  

Inflammation/Immunology

Tarafenacin (SVT-40776) D-tartrate is an orally active, selective M3 muscarinic receptor (M3 muscarinic receptor) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin D-tartrate does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin D-tartrate can be used in the research of overactive bladder .
loading...
    loading...
Cat. No.: HY-123778
CAS No.: 2222737-15-5
Target:  

mAChR

Research Areas:  

Neurological Disease

VU6007678 is a CNS-penetrant muscarinic acetylcholine receptor (mAChR) modulator. VU6007678 potentiates acetylcholine-mediated signaling at human M1, M3, M5 and rat M1, M3, M4, M5 muscarinic acetylcholine receptors. VU6007678 is applicable to research related to Alzheimer's disease, schizophrenia, and ischemic stroke .
loading...
    loading...
Cat. No.: HY-14825
CAS No.: 385367-47-5
Synonyms: SVT-40776
Target:  

mAChR

Research Areas:  

Inflammation/Immunology

Tarafenacin (SVT-40776) is an orally active, selective M3 muscarinic receptor (M3 muscarinic receptor) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin can be used in the research of overactive bladder .
loading...
    loading...
Cat. No.: HY-107651R
CAS No.: 1208222-39-2
Research Areas:  

Metabolic Disease

VU 0365114 (Standard) is the analytical standard of VU 0365114 (HY-107651). This product is intended for research and analytical applications. VU 0365114 is a selective mAChR M5 positive allosteric modulator, with an EC50 of 2.7 μM, and >30 μM for M1, M2, M3 and M4 receptors. VU 0365114 increases insulin secretion stimulated by ACh in human β-cells .
loading...
    loading...
Cat. No.: HY-184883
CAS No.: 2746405-41-2
Target:  

mAChR

Research Areas:  

Neurological Disease

VU6035406 is a functionally selective mAChR inhibitor, with mAChR IC50 values of 21 nM, 51 nM and 47 nM against human, rat and mouse targets, respectively. VU6035406 does not act as a P-glycoprotein substrate. VU6035406 shows extremely low inhibitory activity against cytochrome P450 1A2, 2C9, 2D6 and 3A4. VU6035406 can be used in the research of neurological and psychiatric disorders .
loading...
    loading...